This photo provided Oct. 9, 2012, by the Minnesota Department of Health shows shows vials of the injectable steroid product made by New England Compounding Center implicated in a fungal meningitis outbreak that were being shipped to the Centers for Disease Control and Prevention in Atlanta from Minneapolis. About 17,700 single-dose vials of the steroid sent to 23 states have been recalled. The outbreak involves 10 states, including Minnesota. (AP Photo/Minnesota Department of Health)
NASHVILLE, Tenn. (AP) -- Members of the Tennessee Board of Pharmacists will be discussing additional measures the state could take in regulating compounding pharmacies in the wake of a multistate outbreak of fungal meningitis that has sickened hundreds of people across the country.
Doctors in Tennessee were among the first to link the outbreak to steroid injections prepared by a Massachusetts compounding pharmacy. Across the county, 45 people, including 14 in Tennessee, have died after getting the shots.
A task force formed by the state board to look at state laws in regard to compounding pharmacies is expected to make recommendations during a meeting on Thursday morning.
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to firstname.lastname@example.org. Please provide detailed information.